Suchergebnisse - "Vanella, Vito"

PubPharm (11)

1

IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab

enthalten in: Journal of translational medicine | 2023

von Mallardo, D. | Simeone, E. | Festino, L. | +18

2

Long-term outcomes and persistent toxicities following BRAF/MEK inhibitor therapy for advanced melanoma

enthalten in: European journal of cancer (Oxford, England : 1990) | 2023

von Goodman, R. | Di Guardo, L. | Maurichi, A. | +20

3

Nivolumab serum concentration in metastatic melanoma patients could be related to outcome and enhanced immune activity : a gene profiling retrospective analysis

enthalten in: Journal for immunotherapy of cancer | 2022

von Mallardo, D. | Giannarelli, D. | Vitale, M. | +20

ErratumIn: J Immunother Cancer. 2023 Jul;11(7):. - PMID 37419512

4

Altered Frequencies and Functions of Innate Lymphoid Cells in Melanoma Patients Are Modulated by Immune Checkpoints Inhibitors

enthalten in: Frontiers in immunology | 2022

von Cristiani, C. | Capone, M. | Garofalo, C. | +10

5

Identification of a miRNA-based non-invasive predictive biomarker of response to target therapy in BRAF-mutant melanoma

enthalten in: Theranostics | 2022

von Ruggiero, C. | Fattore, L. | Terrenato, I. | +19

6

PD-L1+ neutrophils as novel biomarkers for stage IV melanoma patients treated with nivolumab

enthalten in: Frontiers in immunology | 2022

von Cristinziano, L. | Modestino, L. | Capone, M. | +11

7

Clinical Outcomes and Toxic Effects of Single-Agent Immune Checkpoint Inhibitors Among Patients Aged 80 Years or Older With Cancer : A Multicenter International Cohort Study

enthalten in: JAMA oncology | 2021

von Nebhan, C. | Cortellini, A. | Ma, W. | +42

8

Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/ Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors : A multicentre analysis of immune-related adverse events

enthalten in: European journal of cancer (Oxford, England : 1990) | 2020

von Cortellini, A. | Bersanelli, M. | Santini, D. | +35

9

Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors : an insight from clinical practice

enthalten in: Journal of translational medicine | 2019

von Cortellini, A. | Vitale, M. | De Galitiis, F. | +22

10

The Role of BRAF-Targeted Therapy for Advanced Melanoma in the Immunotherapy Era

enthalten in: Current oncology reports | 2019

von Vanella, V. | Festino, L. | Trojaniello, C. | +4